COMMUNIQUÉS West-GlobeNewswire

TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 28th Annual Meeting

28/04/2025 - 22:53

WALTHAM, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies [...]

ARCPOINT REPORTS 2024 YEAR END FINANCIAL RESULTS AND ANNOUNCES MANAGEMENT CHANGE

28/04/2025 - 23:00

Greenville, South Carolina, April 28, 2025 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “ Company ” or “ ARCpoint ”) is pleased to report that it has filed its 2024 year end, audited Financial Statements and [...]

ElevateBio Announces Presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting

28/04/2025 - 23:05

– Oral and poster presentations will highlight advancements from ElevateBio’s two business units: Life Edit, its gene editing and R&D technology business, and BaseCamp ® , its process development and cGMP [...]

Telix's Illuccix PSMA-PET Imaging Agent Approved in France

29/04/2025 - 00:30

New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agent MELBOURNE, Australia, April 29, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the [...]

UK Company, Stablepharma Ltd, enters Phase 1 Clinical Trials with world-first Fridge-Free Tetanus & Diphtheria Vaccine

29/04/2025 - 01:01

LONDON, April 29, 2025 (GLOBE NEWSWIRE) -- Following MHRA approval, Stablepharma Ltd has commenced a Phase 1 clinical trial with its lead candidate, fridge-free tetanus and diphtheria vaccine, SPVX02. The Phase 1, first [...]

Mesoblast Appoints Corporate Finance Leader Lyn Cobley To Board

29/04/2025 - 01:44

NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has appointed Lyn Cobley to its Board of [...]

IBA – ACQUISITION D’ACTIONS PROPRES

28/04/2025 - 19:15

Publication immédiate – 28 avril 2025 Louvain-la-Neuve, Belgique, 28 avril 2025 - Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam [...]

IBA – ACQUISITION OF OWN SHARES

28/04/2025 - 19:15

Immediate Release – April 28 th , 2025 Louvain-la-Neuve, Belgium, April 28 th , 2025 - In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion [...]

RECORDATI: 2025-2027 THREE-YEAR PLAN APPROVED FY 2027 TARGETS OF REVENUE BETWEEN € 3,000 AND € 3,200 MILLION; EBITDA(1) BETWEEN € 1,140 AND € 1,225 MILLION; ADJUSTED NET INCOME(2) BETWEEN € 770 AND € 820 MILLION

28/04/2025 - 19:18

RECORDATI: 2025-2027 THREE-YEAR PLAN APPROVED FY 2027 TARGETS OF REVENUE BETWEEN € 3,000 AND € 3,200 MILLION; EBITDA (1) BETWEEN € 1,140 AND € 1,225 MILLION; ADJUSTED NET INCOME (2) BETWEEN € 770 AND € 820 MILLION Milan [...]

SARMs Cardarine GW 50156: Cardarine For Sale, Cardarine Cycle, Cardarine Benefits, Cardarine Dosage, Cardarine Before and After, Cardarine Effects, Cardarine Side Effects, Buy, (C-Dine By CrazyBulk)

28/04/2025 - 19:21

New York City, April 28, 2025 (GLOBE NEWSWIRE) -- “C-DINE 501516 is an all natural, safe, and legal CARDARINE GW501516 alternative that delivers natural ingredients to help fire-up your metabolism and transition your [...]

Relmada Therapeutics Presents Positive Initial Phase 2 NDV-01 Data at AUA2025

28/04/2025 - 19:38

90% of patients achieved high grade disease-free status at any time point with NDV-01, demonstrating strong proof-of-concept for sustained-release “GEM/DOCE” formulation* NDV-01 showed promising clinical activity in BCG [...]

Sugar Defender Reviews [Blood Sugar Control Supplement 2025] User Complaints, Ingredients and Possible Side Effects?

28/04/2025 - 20:13

Sugar Defender's Secret Formula Finally Revealed – How It Supports Healthy Blood Sugar Naturally Albany, New York, April 28, 2025 (GLOBE NEWSWIRE) -- Sugar Defender's Secret Formula Finally Revealed – Know How It [...]

Best Testosterone Boosters for Muscle Gain: Top Rated Testosterone Pills for Bodybuilding & Muscle Growth From TestoPrime

28/04/2025 - 20:15

Boost muscle gain, crush erectile dysfunction, and reclaim peak vitality naturally with top natural testosterone boosters like TestoPrime, powered by D-Aspartic Acid, Fenugreek, KSM-66 Ashwagandha, and Panax Ginseng. [...]

Supra Keto ACV Gummies: Best Gummies for Weight Loss 2025 - (Keto BHB + Keto Plus)

28/04/2025 - 20:32

New York, April 28, 2025 (GLOBE NEWSWIRE) -- Within the weight loss supplement industry, Supra Keto BHB + ACV Gummies are revolutionary, employing two of the best fat-burning compounds: Beta-Hydroxybutyrate (BHB) and [...]

Frontier Medicines Unveils New Preclinical Data for FMC-220, a First-in-Class Covalent p53 Y220C Activator, at AACR 2025

28/04/2025 - 21:30

Sustained reactivation of mutant p53 drives durable anti-tumor activity across models, including KRAS co-mutant tumors FMC-220 selectively stabilizes p53 Y220C at lower doses, overcoming key limitations of non-covalent [...]

Cronos Group Inc. to Hold Virtual 2025 Annual Meeting of Shareholders

28/04/2025 - 22:00

TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 Annual Meeting of Shareholders on Friday, June 20, 2025, at 11:00 a.m. ET. Cronos [...]

CytomX Therapeutics Presents Preclinical Data for mRNA Encoded Masked IL-12 Molecule in Collaboration with Moderna at AACR Annual Meeting

28/04/2025 - 22:00

Novel engineering approach to developing an mRNA-encoded masked IL-12 therapeutic demonstrates potent anti-tumor activity with significantly enhanced tolerability SOUTH SAN FRANCISCO, Calif., April 28, 2025 (GLOBE [...]

Nurix Therapeutics Presents Data at the AACR 2025 Annual Meeting Highlighting the Transformative Potential of Its Proprietary DEL-AI Platform Leveraging Machine Learning to Speed the Discovery of Novel Drugs

28/04/2025 - 22:00

Nurix’s DEL-AI platform uses a first-in-class DEL Foundation Model trained on the Company’s proprietary DNA encoded library data Nurix’s DEL Foundation Model can accurately predict novel binders to therapeutically [...]

Olon Group Strengthens Its Leadership in Bioproduction with Two Strategic Appointments in France

28/04/2025 - 16:01

MILAN, April 28, 2025 (GLOBE NEWSWIRE) -- Olon Group, a leading global pharmaceutical CDMO, announces the appointment of Jérôme Bédier as CEO of its French entities and Andrea Conforto as M&S VP CDMO of Olon Biotech [...]